Prevalence and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

Lignende værker

• The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the START bone mineral density substudy
  af: Carr, Andrew, et al.
  Udgivet: (2019)
• Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial
  af: Hoy, Jennifer F, et al.
  Udgivet: (2017)
• Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART Body Composition Substudy
  af: Hoy, Jennifer, et al.
  Udgivet: (2013)
• Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
  af: Denning, Eileen, et al.
  Udgivet: (2015)
• Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study
  af: Babiker, Abdel G, et al.
  Udgivet: (2012)